The same observations were confirmed in women affected by PCOS (59, 60), indicating that myo-Ins is an effective insulin sensitizer and strengthening the idea that its administration provides a useful approach for some metabolic disorders (44). The gene discussed is INS; the disease is polycystic ovary syndrome.